Why PDRN Keeps Appearing Everywhere
There is a strange shift happening in aesthetic medicine.
Some of the treatments being discussed most enthusiastically aren't really trying to fill anything. They aren't primarily designed to add volume or change the shape of the face. Instead, the idea is to influence the tissue itself.
PDRN. Polynucleotides. Hyaluronic acid. Collagen stimulators.
They are different materials, with different structures and proposed mechanisms, yet they increasingly appear in the same conversation.
Can we change the behaviour of the tissue rather than simply change its shape?
That question is what makes PDRN interesting.
Not the marketing around it.
The biology.
So what actually is PDRN?
PDRN stands for polydeoxyribonucleotide. It is made up of DNA-derived fragments, commonly sourced from purified salmonid DNA.
That sounds rather dramatic when you first hear it, but PDRN isn't being injected as intact genetic material. It is a mixture of DNA-derived polymers that are broken down by enzymes in the tissue into smaller nucleotide components. These breakdown products can then participate in signalling pathways and be recycled by cells through the nucleotide salvage pathway.
Read the review on PDRN and PN
The interesting part happens at the cellular level
One of the proposed mechanisms involves adenosine A2A receptor signalling, which is associated with pathways involved in inflammation, angiogenesis and tissue repair. PDRN has also been studied in relation to fibroblast activity and the extracellular environment surrounding cells.
This makes the idea rather different from simply putting something into the skin to occupy space.
The question becomes whether the material can influence the environment in which cells are trying to repair and function.
That distinction matters because a plausible biological mechanism is not automatically the same thing as a proven clinical outcome.
PDRN isn't the same thing as PN
This is where aesthetic terminology becomes surprisingly messy.
PDRN and PN are related, but they are not necessarily the same material.
Both are DNA-derived polymers, but they can differ in molecular size and structure. A 2025 review proposes a 1500 kDa distinction, describing small and medium chains below 1500 kDa as PDRN and longer chains at or above 1500 kDa as PN. The authors suggest that molecular size can influence the physical and biological properties of these materials. Read the review on PDRN and PN
The terminology is still inconsistent, though, with PDRN and PN sometimes being used interchangeably in the literature. The review was published partly to address this confusion and proposes the 1500 kDa cutoff as a standardised way of distinguishing the two.
So does it actually stimulate collagen?
Possibly, but I think this is one of those phrases that has become too simple.
Collagen production isn't a single switch. It involves fibroblasts, growth factors, inflammatory signalling, mechanical cues and the extracellular matrix surrounding the cells.
PDRN may influence some of these processes, but that doesn't make it equivalent to every other treatment described as a "collagen stimulator".
This is one reason I find the broader idea of bioremodelling more interesting than the phrase "skin booster".
It asks what is happening to the tissue rather than simply what ingredient was injected.
What does the evidence actually show?
A 2025 systematic review of polynucleotides in aesthetic medicine identified nine studies involving 219 patients. The studies reported promising improvements in areas such as wrinkles, skin texture and elasticity, but the authors found considerable variation in treatment areas, injection techniques, protocols and outcome measures. The included studies were considered low or moderate quality.
That doesn't mean the treatment doesn't work.
It means we don't yet have the kind of large, consistent evidence base that would allow us to make very confident claims about exactly how well it works, for whom, and under which protocol.
That distinction is important because aesthetics can move very quickly from:
There is a biological mechanism.
to:
This regenerates your skin.
Those are not the same statement.
There is some genuinely interesting human evidence
PDRN isn't only a laboratory story.
A 2026 narrative review examined evidence around PDRN and post-procedure recovery, including human studies and preclinical research involving skin repair. The authors describe evidence relating to re-epithelialisation, erythema, scarring and other aspects of recovery, while also pointing out the limitations: small samples, variation between formulations and a lack of long-term follow-up. Original Study
So there is a real scientific story here, but it isn't quite the same story as “Inject this and your skin regenerates.” The research is more interesting than that. It gives us clues about signalling, repair and tissue behaviour, while still leaving plenty of questions about what those mechanisms mean in human facial skin.
Read the 2026 review on PDRN and post-procedure recovery
And then there is the beauty industry
This is where things get especially interesting.
PDRN and PN have moved from relatively specialised regenerative and dermatological applications into the language of everyday aesthetics, appearing in skin boosters, injectables and post-procedure protocols.
The language has changed too. We hear less about simply filling wrinkles and more about skin quality, bioremodelling, regeneration, collagen, repair and tissue health.
Some of those concepts have a strong biological basis, while others are being used rather loosely. Perhaps that is exactly why the subject deserves a closer look.
The interesting question isn't whether "PDRN is good".
It is:
What biological effect are we actually trying to create?
Different materials. Different jobs.
It is tempting to put everything into one category, particularly when so many treatments are described using the same language of "biostimulation" or "skin quality".
But HA, PDRN, PN, CaHA and PLLA are not the same thing. They have different structures, interact with tissue differently and have different proposed mechanisms and evidence bases.
That doesn't mean one is automatically better than another.
It means the more interesting question is what biological problem are we actually trying to influence?
From measuring skin to changing it
This brings us back to the little trail we've been following through Cesence.
First, we asked how skin ageing can be measured. Then we looked at how researchers are trying to recreate aspects of ageing skin in the laboratory. Now we're looking at the other side of the equation.
What happens when we stop simply measuring the tissue and start trying to change its behaviour?
That is where PDRN becomes interesting.
Not because it is a miracle, and not because every claim made about it has been proven.
But because it sits inside a much bigger shift in aesthetic medicine. We are becoming increasingly interested in the biology of the tissue itself.
And perhaps the next generation of aesthetic treatments won't be defined simply by what they add to the face.
They may be defined by what they can persuade the tissue to do.
That's the part I'm curious about.
C·🌷
Research notes
PDRN and PN in dermatology From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional Biomolecules. Read the review
Polynucleotides in aesthetic medicine Lee et al., 2024 Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness. Read the full review
Clinical evidence for polynucleotides The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. Read the systematic review
PDRN and post-procedure recovery 2026 Polydeoxyribonucleotide (PDRN) in Post-procedure Recovery in Aesthetic Medicine: A Narrative Review. Read the full review
PDRN versus PN Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives. Read the review